Paper30008698
Neuropeptide G Protein-Coupled Receptors as Oncotargets.
Moody TW and 2 others. Front Endocrinol (Lausanne), 2018. Cited by 46 papers, by iCite.
Cite this record
ConductScience Library. Neuropeptide G Protein-Coupled Receptors as Oncotargets. Papers, record 30008698. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30008698
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| ZIADK053100 | NIH | NIH RePORTER | |||
| ZIADK053101 | NIH | NIH RePORTER |
References134
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20008985 | Imaging spontaneous MMTVneu transgenic murine mammary tumors: targeting metabolic activity versus genetic products. | J Nucl Med | 2010 | https://conductscience.org/library/papers/20008985 | PubMed |
| 2 | 25249545 | Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib. | Oncotarget | 2014 | https://conductscience.org/library/papers/25249545 | PubMed |
| 3 | 9533649 | (Arg15, Arg21) VIP: evaluation of biological activity and localization to breast cancer tumors. | Peptides | 1998 | https://conductscience.org/library/papers/9533649 | PubMed |
| 4 | 22443209 | Efficient siRNA targeted delivery into cancer cells by gastrin-releasing peptides. | Bioconjug Chem | 2012 | https://conductscience.org/library/papers/22443209 | PubMed |
| 5 | 15112052 | New approaches to therapy of cancers of the stomach, colon and pancreas based on peptide analogs. | Cell Mol Life Sci | 2004 | https://conductscience.org/library/papers/15112052 | PubMed |
| 6 | 28923213 | Long-acting somatostatin analogues in the treatment of unresectable/metastatic neuroendocrine tumors. | Semin Oncol | 2017 | https://conductscience.org/library/papers/28923213 | PubMed |
| 7 | 21141436 | Utility of ProGRP determinations in cancer patients. | Clin Lab | 2010 | https://conductscience.org/library/papers/21141436 | PubMed |
| 8 | 25698233 | A structure-function study of PACAP using conformationally restricted analogs: Identification of PAC1 receptor-selective PACAP agonists. | Peptides | 2015 | https://conductscience.org/library/papers/25698233 | PubMed |
| 9 | 21625560 | Crystal structure of the PAC1R extracellular domain unifies a consensus fold for hormone recognition by class B G-protein coupled receptors. | PLoS One | 2011 | https://conductscience.org/library/papers/21625560 | PubMed |
| 10 | 26702849 | Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancer. | Curr Opin Endocrinol Diabetes Obes | 2016 | https://conductscience.org/library/papers/26702849 | PubMed |
| 11 | 1671171 | Molecular cloning of the bombesin/gastrin-releasing peptide receptor from Swiss 3T3 cells. | Proc Natl Acad Sci U S A | 1991 | https://conductscience.org/library/papers/1671171 | PubMed |
| 12 | 22289055 | Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. | Br J Pharmacol | 2012 | https://conductscience.org/library/papers/22289055 | PubMed |
| 13 | 27635672 | Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies. | Expert Opin Pharmacother | 2016 | https://conductscience.org/library/papers/27635672 | PubMed |
| 14 | 19101605 | Vasoactive intestinal peptide (VIP) induces transactivation of EGFR and HER2 in human breast cancer cells. | Mol Cell Endocrinol | 2009 | https://conductscience.org/library/papers/19101605 | PubMed |
| 15 | 29043413 | Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice. | Cancer Immunol Immunother | 2018 | https://conductscience.org/library/papers/29043413 | PubMed |
| 16 | 15068615 | Role of 99mTc-bombesin scan in diagnosis and staging of prostate cancer. | Cancer Biother Radiopharm | 2004 | https://conductscience.org/library/papers/15068615 | PubMed |
| 17 | 26743514 | Octreotide and Lanreotide in Gastroenteropancreatic Neuroendocrine Tumors. | Curr Oncol Rep | 2016 | https://conductscience.org/library/papers/26743514 | PubMed |
| 18 | 29120923 | Carcinoid-syndrome: recent advances, current status and controversies. | Curr Opin Endocrinol Diabetes Obes | 2018 | https://conductscience.org/library/papers/29120923 | PubMed |
| 19 | 16901586 | Functional domains of the subtype 1 neurotensin receptor (NTS1). | Peptides | 2006 | https://conductscience.org/library/papers/16901586 | PubMed |
| 20 | 22389426 | Pituitary adenylate cyclase-activating polypeptide causes tyrosine phosphorylation of the epidermal growth factor receptor in lung cancer cells. | J Pharmacol Exp Ther | 2012 | https://conductscience.org/library/papers/22389426 | PubMed |
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41465475 | Exploring the Link Between PACAP Signalling and Hyaluronic Acid Production in Melanoma Progression. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41465475 | PubMed |
| 41387675 | Structure-based design of macrocyclic peptides to generate functional antibodies against G protein-coupled receptors. | Nat Commun | 2025 | https://conductscience.org/library/papers/41387675 | PubMed |
| 41342973 | Investigation of vasoactive intestinal peptide expression and significance in a congenital diaphragmatic hernia animal model. | Pediatr Surg Int | 2025 | https://conductscience.org/library/papers/41342973 | PubMed |
| 40487638 | The neuroscience of cancer: Focus on neuropeptidergic systems. | Acta Pharm Sin B | 2025 | https://conductscience.org/library/papers/40487638 | PubMed |
| 39518025 | Differentially Expressed Somatostatin (SST) and Its Receptors (SST1-5) in Sporadic Colorectal Cancer and Normal Colorectal Mucosa. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39518025 | PubMed |
| 38777339 | Cholecystokinin neurotransmission in the central nervous system: Insights into its role in health and disease. | Biofactors | 2024 | https://conductscience.org/library/papers/38777339 | PubMed |
| 38020178 | GRPR-targeting radiotheranostics for breast cancer management. | Front Med (Lausanne) | 2023 | https://conductscience.org/library/papers/38020178 | PubMed |
| 37508387 | Peptide G-Protein-Coupled Receptors and ErbB Receptor Tyrosine Kinases in Cancer. | Biology (Basel) | 2023 | https://conductscience.org/library/papers/37508387 | PubMed |
| 37385990 | Neurokinin-1 receptor drives PKCɑ-AURKA/N-Myc signaling to facilitate the neuroendocrine progression of prostate cancer. | Cell Death Dis | 2023 | https://conductscience.org/library/papers/37385990 | PubMed |
| 36497331 | NPFFR2 Contributes to the Malignancy of Hepatocellular Carcinoma Development by Activating RhoA/YAP Signaling. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36497331 | PubMed |
| 36313439 | Molecular subtypes based on cuproptosis-related genes and immune profiles in lung adenocarcinoma. | Front Genet | 2022 | https://conductscience.org/library/papers/36313439 | PubMed |
| 36220861 | Transcription profiling of feline mammary carcinomas and derived cell lines reveals biomarkers and drug targets associated with metabolic and cell cycle pathways. | Sci Rep | 2022 | https://conductscience.org/library/papers/36220861 | PubMed |
| 35932909 | Adding of neurotensin to non-small cell lung cancer cells increases tyrosine phosphorylation of HER3. | Peptides | 2022 | https://conductscience.org/library/papers/35932909 | PubMed |
| 35644465 | The Nonpeptide Agonist MK-5046 Functions As an Allosteric Agonist for the Bombesin Receptor Subtype-3. | J Pharmacol Exp Ther | 2022 | https://conductscience.org/library/papers/35644465 | PubMed |
| 35267558 | Predictive Factors for Resistant Disease with Medical/Radiologic/Liver-Directed Anti-Tumor Treatments in Patients with Advanced Pancreatic Neuroendocrine Neoplasms: Recent Advances and Controversies. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35267558 | PubMed |
| 35011543 | The Role of Neuropeptide-Stimulated cAMP-EPACs Signalling in Cancer Cells. | Molecules | 2022 | https://conductscience.org/library/papers/35011543 | PubMed |
| 34829972 | Somatostatin and Its Receptor System in Colorectal Cancer. | Biomedicines | 2021 | https://conductscience.org/library/papers/34829972 | PubMed |
| 34539578 | Bombesin Receptor Family Activation and CNS/Neural Tumors: Review of Evidence Supporting Possible Role for Novel Targeted Therapy. | Front Endocrinol (Lausanne) | 2021 | https://conductscience.org/library/papers/34539578 | PubMed |
| 34070457 | Emerging Molecular Receptors for the Specific-Target Delivery of Ruthenium and Gold Complexes into Cancer Cells. | Molecules | 2021 | https://conductscience.org/library/papers/34070457 | PubMed |
| 32964398 | The G Protein-Coupled Receptor PAC1 Regulates Transactivation of the Receptor Tyrosine Kinase HER3. | J Mol Neurosci | 2021 | https://conductscience.org/library/papers/32964398 | PubMed |
Genes53
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30008698
GET https://conductscience.org/api/papers/v1/30008698/references?page=2